Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential
Molecules · 01.02.2025 · 30 (3) · 654
DOI: 10.3390/molecules30030654 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 01.02.2025. Verfasst von Lucia Capasso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via L. De Crecchio 7, 80138 Naples, Italy. Hauptthemen laut MEDLINE: Catechin, Antioxidants. Die Arbeit wurde bisher 274-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epigallocatechin gallate (EGCG), the predominant catechin in green tea, comprises approximately 50% of its total polyphenol content and has garnered widespread recognition for its significant therapeutic potential. As the principal bioactive component of Camellia sinensis, EGCG is celebrated for its potent antioxidant, anti-inflammatory, cardioprotective, and antitumor properties. The bioavailability and metabolism of EGCG within the gut microbiota underscore its systemic effects, as it is absorbed in the intestine, metabolized into bioactive compounds, and transported to target organs. This compound has been shown to influence key physiological pathways, particularly those related to lipid metabolism and inflammation, offering protective effects against a variety of diseases. EGCG’s ability to modulate cell signaling pathways associated with oxidative stress, apoptosis, and immune regulation highlights its multifaceted role in health promotion. Emerging evidence underscores EGCG’s therapeutic potential in preventing and managing a range of chronic conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and metabolic syndromes. Given the growing prevalence of lifestyle-related diseases and the increasing interest in natural compounds, EGCG presents a promising avenue for novel therapeutic strategies. This review aims to summarize current knowledge on EGCG, emphasizing its critical role as a versatile natural bioactive agent with diverse clinical applications. Further exploration in both experimental and clinical settings is essential to fully unlock its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Precision Medicine, University of Campania Luigi Vanvitelli, Via L. De Crecchio 7, 80138 Naples, Italy.
- National Research Council (CNR), Institute of Biosciences and BioResources (IBBR), Via Università 133, 80055 Portici, Italy.
- Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via Domenico Montesano 49, 80131 Naples, Italy.
- Department of Life Science, Health, and Health Professions, Link Campus University, 00165 Rome, Italy.
- Department of Biology, University of Naples Federico II, 80126 Naples, Italy.
ORCID-Profile: Lucia Capasso, Luigi De Masi, Viviana Maresca, Angela Nebbioso, Daniela Rigano
Zitieren
APA
Capasso, L., De Masi, L., Sirignano, C., Maresca, V., Basile, A., Nebbioso, A., Rigano, D., & Bontempo, P. (2025). Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential. Molecules, 30(3), 654. https://doi.org/10.3390/molecules30030654
Vancouver
Capasso L, De Masi L, Sirignano C, Maresca V, Basile A, Nebbioso A, et al. Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential. Molecules. 2025;30(3):654. doi:10.3390/molecules30030654
BibTeX
@article{Capasso2025,
author = {Capasso, Lucia and De Masi, Luigi and Sirignano, Carmina and Maresca, Viviana and Basile, Adriana and Nebbioso, Angela and Rigano, Daniela and Bontempo, Paola},
title = {Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential},
journal = {Molecules},
year = {2025},
volume = {30},
number = {3},
pages = {654},
doi = {10.3390/molecules30030654}
}
EUVIMED